Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07316517Not ApplicableNot Yet Recruiting

Versius Clinical Study in Robot Assisted Inguinal Hernia Repair Surgery

Role: lead

NCT07289295Not ApplicableRecruiting

Versius Gynecology Study

Role: lead

NCT07096856Not ApplicableNot Yet Recruiting

Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System

Role: lead

NCT06112535Not ApplicableCompleted

Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic Surgery

Role: lead

NCT06539442Not ApplicableRecruiting

Versius Paediatrics Study

Role: lead

All 5 trials loaded